Suzanne M. Cadden
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Suzanne M. Cadden
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
18
| Extinct | Miscellaneous Commercial Services | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Suzanne M. Cadden via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
U.S. Bioscience, Inc.
U.S. Bioscience, Inc. BiotechnologyHealth Technology U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA. | Biotechnology | President | |
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | President | |
DR. REDDY'S LABORATORIES LIMITED | Pharmaceuticals: Major | Director/Board Member | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Director/Board Member | |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Miscellaneous Commercial Services | Director/Board Member | |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman | |
XENCOR, INC. | Biotechnology | Chairman | |
ALDEYRA THERAPEUTICS, INC. | Biotechnology | Chairman | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
moksha8 Pharmaceuticals, Inc.
moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
CorMatrix Cardiovascular, Inc.
CorMatrix Cardiovascular, Inc. Medical SpecialtiesHealth Technology CorMatrix Cardiovascular, Inc. develops and markets commercial medical devices. It offers CorMatrix CanGaroo, Vascular Repair, Pericardial Repair & Reconstruction, Tyke, and Cardiac Tissue Repair. The company was founded by David B. Camp and Robert G. Matheny in 2001 and is headquartered in Roswell, GA. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
FluGen, Inc.
FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Chairman | |
Mati Therapeutics, Inc.
Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Biotechnology | Founder Director of Finance/CFO Founder | |
BIOTA HOLDINGS LTD. | Pharmaceuticals: Major | Director/Board Member | |
Queen Elizabeth College | College/University | Doctorate Degree | |
The University of Texas at Austin | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman | |
University of Calgary | College/University | Graduate Degree | |
ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
University of Birmingham | College/University | Undergraduate Degree | |
The University of Nottingham | College/University | Undergraduate Degree | |
REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member | |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chairman | |
Red Sky Partners LLC | Corporate Officer/Principal | ||
Patheon Biologics LLC
Patheon Biologics LLC BiotechnologyHealth Technology Patheon Biologics LLC manufactures, supplies clinical and commercial bulk biologics to the biopharmaceutical industry. The company was founded in 2010 and is headquartered in Jefferson City, MO. | Biotechnology | Director/Board Member | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Chairman | |
Beacon Street Advisors LLC
Beacon Street Advisors LLC Miscellaneous Commercial ServicesCommercial Services Beacon Street Advisors LLC provides financial services. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lakewood-Amedex, Inc.
Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL. | Pharmaceuticals: Major | Director/Board Member | |
VAXART, INC. | Biotechnology | Director/Board Member | |
NUVATION BIO INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 41 |
Verenigd Koninkrijk | 5 |
Canada | 3 |
India | 2 |
Denemarken | 2 |
Sectoraal
Health Technology | 38 |
Commercial Services | 6 |
Consumer Services | 6 |
Finance | 2 |
Process Industries | 2 |
Operationeel
Director/Board Member | 132 |
Independent Dir/Board Member | 58 |
Director of Finance/CFO | 33 |
Chairman | 30 |
Corporate Officer/Principal | 29 |
Sterkste connecties
Insiders | |
---|---|
Kathryn Falberg | 30 |
John Thomas | 30 |
Bruce Carter | 25 |
Joseph Turner | 22 |
John Kozarich | 21 |
Geoffrey F. Cox | 20 |
Jason Aryeh | 18 |
Vicente J. Anido | 16 |
Jeffrey Meckler | 15 |
C. Boyd Clarke | 15 |
Stephen Sabba | 9 |
Ian John Massey | 9 |
Robert Lee Butchofsky | 5 |
Christopher Muller | 4 |
Cameron R. Nelson | 4 |
- Beurs
- Insiders
- Suzanne M. Cadden
- Bedrijfsconnecties